Industry NewsRevolutionary Metagenomic Discovery Service Assembles Individual Reference-Quality Genomes
Industry NewsNew Test Which Identifies Head and Neck Cancer Patients Most Likely to Benefit from Opdivo (nivolumab) is Approved for Use in Europe
Industry NewsScientists’ Choice Awards Nominations Open for Best New Clinical Laboratory Product of 2016